Topas Therapeutics
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $64M
Investors
- 7
About Topas Therapeutics
Founded in 2013 and headquartered in Hamburg, Germany, Topas Therapeutics GmbH develops solutions to modulate immune responses.41 mn.Topas Therapeutics focuses on innovative therapeutic solutions aimed at addressing autoimmune diseases and allergies. The company's core product offerings revolve around proprietary technology that enhances the delivery of biologic medicines, including peptides and proteins, through a unique nanoparticle platform. This platform allows for targeted therapy that aims to modulate the immune response, thereby offering potential treatments for conditions such as diabetes and multiple sclerosis. Topas Therapeutics primarily serves biopharmaceutical companies and research institutions in North America and Europe, leveraging partnerships to advance the development and commercialization of its therapies.Topas Therapeutics generates revenue through strategic partnerships and collaborations with biopharmaceutical firms and research organizations, which include licensing agreements and co-development initiatives. These transactions are structured around the commercialization of their proprietary technology and related therapeutics, potentially involving milestone payments and royalties based on product sales. As a B2B enterprise, the company focuses on delivering its innovative solutions to its partners, which ultimately reach healthcare providers and patients. The company is targeting expansion into new geographic regions, with specific markets in North America and Europe identified for further outreach and development initiatives. In January 2026, The Tofoo Company Limited, a portfolio company of Comitis Capital, agreed to acquire Topas Therapeutics GmbH from Epidarex Capital, BioMed Partners, EMBL Ventures, Vesalius Biocapital, Gimv, Boehringer Ingelheim Venture, and Evotec SE. The deal is expected to be completed later this month.
Who invested in Topas Therapeutics
7 investors across 4 rounds
See all investors in Topas Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Topas Therapeutics
Who invested in Topas Therapeutics?
Topas Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Topas Therapeutics raised?
Topas Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Topas Therapeutics last raise money?
Topas Therapeutics's most recent round on record is a Series B, in Jun 2021.
What does Topas Therapeutics do?
Founded in 2013 and headquartered in Hamburg, Germany, Topas Therapeutics GmbH develops solutions to modulate immune responses.
Where is Topas Therapeutics headquartered?
Topas Therapeutics is headquartered in Hamburg, Germany.
Which VCs invest in companies like Topas Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Topas Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Topas Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.